This technology opportunity engine (TOE) service, Genetic Technology News, depicts the current landscape and the new life sciences trends across drug discoveries accelerated through protein-based techniques.
Special emphasis has been focused on life sciences research through 3D images of megaenzymes and bispecific antibodies, as well as, research collaboration for next generation therapeutics. Relevant advances in Alzheimer's Disease are also profiled through casein kinase delta1 inhibitors. A section with the acute perspective of our analysts through an analysis of patents for novel antibody-based cancer therapies is included. All industry interactions including main contacts are mapped.
Keywords: 3D imaging, megaenzymes, next generation therapeutics, bispecific antibodies, ebola, casein kinase delta1 inhibitors, tau phosphorylation, Alzheimer's Disease, patent analysis, antibody-based therapy, cancer therapy, cancer research.